Table 2.
Baseline characteristics of PCa-patients cohort.
| All | HSPC | mCRPC | |||
|---|---|---|---|---|---|
| ADT Only | ADT + NHT | ADT + CTx | |||
| Patient Number | 97 | 26 | 25 | 33 | 13 |
| Median age at primary diagnosis, years | 73 | 72 | 74 | 71 | 66 |
| Median PSA at primary diagnosis, ng/mL (Interquartile range IQR) | 18 (6.9; 79.0) |
6.3 (2.7; 10.2) |
15.6 (7.2; 87.6) |
49.0 (11.2;128.0) |
60.4 (28.7; 92.7) |
| Neuroendocrine differentiation at primary diagnosis, % | 1.0 | 0.0 | 0.0 | 3.0 | 0.0 |
| Presence of bone metastases at primary diagnosis, % | 25.0 | 3.8 | 20.0 | 30 | 62 |
| Presence of lymph node metastases at primary diagnosis, % | 14 | 12 | 8.0 | 18 | 15 |
| Presence of organ metastases at primary diagnosis, % | 1.00 | 0.00 | 0.0 | 3.0 | 0.0 |
| Median overall survival since the start of primary therapy, months | 59 | 47 | 81 | 67 | 86 |